Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / INCY - Incyte Is A Buy As Ruxolitinib Ramps Revenue And Pipeline Matures

INCY - Incyte Is A Buy As Ruxolitinib Ramps Revenue And Pipeline Matures

Incyte Corporation
  • Jakafi (ruxolitinib) sales were up 15% y/y and the label is expanding.
  • Olumiant is ramping up royalties.
  • Behind approved drugs is an extensive pipeline to build revenue over this decade.

For further details see:

Incyte Is A Buy As Ruxolitinib Ramps Revenue And Pipeline Matures
Stock Information
Company Name: Incyte Corporation
Stock Symbol: INCY
Market: NASDAQ
Website: incyte.com
Menu
INCY INCY Quote INCY Short INCY News INCY Articles INCY Message Board
Get INCY Alerts

News, Short Squeeze, Breakout and More Instantly...